Halozyme Therapeutics, Inc. (HALO)

73.23 -7.25 (-9.01%) USD  |  NASDAQ  |  Feb 18, 16:00
73.30 +0.07 (+0.10%) After-Hours: 07:15
More

Halozyme Therapeutics Operating Income (Quarterly)

Operating Income (Quarterly) Chart

View Operating Income (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly) Range, Past 5 Years

View Operating Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly) Benchmarks

View Operating Income (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Stryker Corp. Upgrade
Skye Bioscience, Inc. Upgrade